Recognition of Li Fraumeni syndrome at diagnosis of a locally advanced extremity rhabdomyosarcoma

Pediatric Blood and Cancer

Volumn 48, Issue 3, 2007, Pages 345-348

  Trahair, T ^a,c   Andrews, L ^b   Cohn, R J ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Li Fraumeni syndrome; p53; Rhabdomyosarcoma; Soft tissue sarcoma

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; VINCRISTINE;

ADJUVANT THERAPY; ADRENAL CORTEX CARCINOMA; ARTICLE; BREAST CANCER; CANCER SURGERY; CASE REPORT; ESOPHAGUS CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FIBROSARCOMA; HISTOPATHOLOGY; HUMAN; LIVER TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOMYOSARCOMA;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; ANTINEOPLASTIC AGENTS; ASTROCYTOMA; BREAST NEOPLASMS; CARCINOMA; CASE MANAGEMENT; CHILD, PRESCHOOL; CODON, NONSENSE; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; LEG; LI-FRAUMENI SYNDROME; LIVER NEOPLASMS; MALE; MUSCLE NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PEDIGREE; RADIOTHERAPY, ADJUVANT; RETROPERITONEAL NEOPLASMS; RHABDOMYOSARCOMA, EMBRYONAL; SARCOMA;

EID: 33846908510     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20795     Document Type: Article

References (20)

1. Diller L, Sexsmith E, Gottlieb A, et al. Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest 1995;95:1606-1611.
2. Hisada M, Garber JE, Fung CY, et al. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 1998;90:606-611.
3. Strong LC, Stine M, Norsted TL. Cancer in survivors of childhood soft tissue sarcoma and their relatives. J Natl Cancer Inst 1987;79:1213-1220.
4. Heyn R, Haeberlen V, Newton WA, et al. Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol 1993;11:262-270.
5. Rich DC, Corpron CA, Smith MB, et al. Second malignant neoplasms in children after treatment of soft tissue sarcoma. J Pediatr Surg 1997;32:369-372.
6. Cohen RJ, Curtis RE, Inskip PD, et al. The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer 2005;103:2391-2396.
7. Crist W, Gehan EA, Ragab AH, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13:610-630.
8. Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 2001;19:3091-3102.
9. Neville HL, Andrassy RJ, Lobe TE, et al. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: A preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). J Pediatr Surg 2000;35:317-321.
10. Nagarajan R, Clohisy DR, Neglia JP, et al. Function and quality-of-life of survivors of pelvic and lower extremity osteosarcoma and Ewing's sarcoma: The Childhood Cancer Survivor Study. Br J Cancer 2004;91:1858-1865.
11. Li FP, Fraumeni JF Jr. Rhabdomyosarcoma in children: Epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst 1969;43:1365-1373.
12. Li FP, Fraumeni JF Jr, Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988;48:5358-5362.
13. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-1238.
14. Chompret A, Brugieres L, Ronsin M, et al. p53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer 2000;82:1932-1937.
15. Bell DW, Varley JM, Szydlo TE, et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 1999;286:2528-2531.
16. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 1993;329:1318-1327.
17. Olivier M, Goldgar DE, Sodha N, et al. Li-Fraumeni and related syndromes: Correlation between tumor type, family structure, and TP53 genotype. Cancer Res 2003;63:6643-6650.
18. Kemp CJ, Wheldon T, Balmain A. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat Genet 1994;8:66-69.
19. Limacher JM, Frebourg T, Natarajan-Ame S, et al. Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome. Int J Cancer 2001;96:238-242.
20. Bertucio CS, Wara WM, Matthay KK, et al. Functional and clinical outcomes of limb-sparing therapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys 2001;49:763-769.